Explorer
Advertisement
![ABP Premium](https://cdn.abplive.com/imagebank/Premium-ad-Icon.png)
Indian Pharma
Business
![Pharma Industry Should Prioritise R&D, Focus On Innovative Products: Union Health Minister](https://feeds.abplive.com/onecms/images/uploaded-images/2023/09/26/465454becf87fef382667e316e5e97561695722982765800_original.jpg?impolicy=abp_cdn&imwidth=200)
Pharma Industry Should Prioritise R&D, Focus On Innovative Products: Union Health Minister
Business
![Indian Pharma Industry To Record Revenue Growth Of 8-10% In FY24: CRISIL](https://feeds.abplive.com/onecms/images/uploaded-images/2023/09/11/970f43a216cb8f35a154113af621363a1694423780129800_original.jpg?impolicy=abp_cdn&imwidth=200)
Indian Pharma Industry To Record Revenue Growth Of 8-10% In FY24: CRISIL
India
![Syrup Deaths: Uzbek, Gambia Incidents 'Not Similar', Indian Pharma Cos Credible Suppliers, Says MEA](https://feeds.abplive.com/onecms/images/uploaded-images/2022/12/29/6015e179d94b51efb43ef3f92fb8d9341672319849991320_original.jpg?impolicy=abp_cdn&imwidth=200)
Syrup Deaths: Uzbek, Gambia Incidents 'Not Similar', Indian Pharma Cos Credible Suppliers, Says MEA
Technology
![Ransomware Attacks, IP And Data Theft Top Concerns For Indian Pharma Firms: DSCI-Deloitte Report](https://feeds.abplive.com/onecms/images/uploaded-images/2022/06/23/4479f5fdb296908195a328da1b55331a_original.jpg?impolicy=abp_cdn&imwidth=200)
Ransomware Attacks, IP And Data Theft Top Concerns For Indian Pharma Firms: DSCI-Deloitte Report
Health
![Corona Vaccine: Serum Institute Becomes First Indian Pharma To Seek Nod For Emergency Use Of Oxford Vaccine In India](https://static.abplive.com/wp-content/uploads/2020/11/14045005/covid.jpg?impolicy=abp_cdn&imwidth=200)
Corona Vaccine: Serum Institute Becomes First Indian Pharma To Seek Nod For Emergency Use Of Oxford Vaccine In India
Business
![Indian pharma growth likely to be moderate: ICRA](https://static.abplive.com/ani-images/ICRAlogo.jpg?impolicy=abp_cdn&imwidth=200)
Indian pharma growth likely to be moderate: ICRA
Business
![Indian pharma growth likely to be moderate: ICRA](https://static.abplive.com/ani-images/ICRAlogo.jpg?impolicy=abp_cdn&imwidth=200)
Indian pharma growth likely to be moderate: ICRA
Short Videos
Advertisement
Advertisement
Advertisement
Top Headlines
India
States
India
India
Advertisement
Trending News
![ABP Premium](https://cdn.abplive.com/imagebank/metaverse-mid.png)